Table 4.
SNP | Position on chrom 4 | Gene | MAF | GWAS ORb | SNCA (probe 29 939) | CTSD (probe 52 556) | GAK exon 26 (probe 155 700) | GAK exon 28 (probe 397 150) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Beta | P-value | Beta | P-value | Beta | P-value | Beta | P-value | |||||
rs1564282 | 842,313 | GAK | 0.14 (T) | 1.7 | 0.35c | 0.003 | −0.06 | 0.49 | −0.12 | 0.16 | −0.15 | 0.03 |
rs356229 | 90,825,620 | 3’ SNCA | 0.44 (C) | 1.35 | −0.03 | 0.70 | 0.02 | 0.73 | −0.01 | 0.87 | −0.01 | 0.83 |
rs356188 | 90,910,560 | SNCA | 0.29 (C) | 0.7 | −0.08 | 0.27 | 0.12 | 0.007 | 0.11 | 0.02 | 0.07 | 0.1 |
rs3775478 | 91,061,863 | MMRN1 | 0.12 (G) | 1.7 | 0.05 | 0.67 | 0.04 | 0.55 | −0.05 | 0.53 | −0.04 | 0.56 |
MAF, minor allele frequency; Beta, beta coefficient.
aAdjusted for PD/control, RIN, PMI and age at death.
bOR previously reported for SNPs association to PD in our Familial PD GWAS (7) with P-values ranging from 5.9 × 10−6 to 8.4 × 10−5.
ceSNP beta estimate in a subset of 32 brain samples with available ethnicity information (all Caucasians) was similar to the beta estimate value in the whole set of brains (Beta = 0.33).